Potential role of circular RNA in cyclosporin A-induced cardiotoxicity in rats

Yanru Zhao1, Yang Li1, Dachuan Fan2

  • 1Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

Insights

Cyclosporin A causes heart toxicity, but circular RNAs (circRNAs) may offer new therapeutic targets. This study identified specific circRNA changes linked to this toxicity, suggesting potential diagnostic and treatment avenues.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Toxicology

Background:

  • Cyclosporin A (CsA) is vital for autoimmune diseases and transplants but causes cardiotoxicity.
  • Circular RNAs (circRNAs) are implicated in cardiovascular disease pathogenesis.
  • Understanding CsA's cardiotoxic mechanisms is crucial for patient safety.

Purpose of the Study:

  • To investigate circRNA expression profiles in CsA-induced cardiotoxicity.
  • To identify potential molecular mechanisms underlying CsA cardiotoxicity.
  • To explore circRNAs as biomarkers or therapeutic targets for CsA cardiotoxicity.

Main Methods:

  • Wistar rats were treated with CsA (15 mg/kg/day) or olive oil for two weeks.
  • Cardiotoxicity was assessed using microscopy and TUNEL staining.
  • circRNA expression was analyzed via microarray, with validation by qRT-PCR.
  • Gene Ontology and KEGG pathway analyses were performed on differentially expressed circRNAs.

Main Results:

  • CsA induced significant cardiotoxicity in rats.
  • Microarray analysis revealed 104 differentially expressed circRNAs (67 upregulated, 37 downregulated).
  • Quantitative real-time PCR confirmed changes in 6 of 12 tested circRNAs.
  • Pathway analysis suggested involvement of autophagy and Hippo signaling.

Conclusions:

  • CsA-induced cardiotoxicity is associated with distinct circRNA expression patterns.
  • Differentially expressed circRNAs may mediate CsA cardiotoxicity via autophagy or Hippo signaling.
  • circRNAs represent promising future biomarkers and therapeutic targets for CsA cardiotoxicity.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
149
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
146
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
901